Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions: Microalbuminuria; Cardiovascular Diseases; Renal Disease Interventions: Drug: Fosinopril; Drug: Pravastatin; Drug: Fosinopril Placebo; Drug: Pravastatin Placebo Sponsors: University Medical Center Groningen; Dutch Kidney Foundation; Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials
Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions: Microalbuminuria; Cardiovascular Diseases; Renal Disease Interventions: Drug: Fosinopril + Pravastatin; Drug: Fosinopril + Placebo; Drug: Pravastatin + Placebo; Drug: Double Placebo Sponsors: University Medical Center Groningen; Dutch Kidney Foundation; Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials
Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions: Microalbuminuria; Cardiovascular Diseases; Renal Disease Interventions: Drug: Fosinopril; Drug: Pravastatin; Drug: Fosinopril Placebo; Drug: Pravastatin Placebo Sponsors: University Medical Center Groningen; Dutch Kidney Foundation; Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials